SIT Graduate Institute/SIT Study Abroad

SIT Digital Collections
Independent Study Project (ISP) Collection

SIT Study Abroad

Spring 2016

Paediatric Tuberculosis in Bhopal, Madhya
Pradesh, India: DOTS, Diagnosis, and
Determinants
Emma Klein
SIT Graduate Institute - Study Abroad

Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection
Part of the Bacterial Infections and Mycoses Commons, Community Health and Preventive
Medicine Commons, Health Policy Commons, Inequality and Stratification Commons, and the
Nutrition Commons
Recommended Citation
Klein, Emma, "Paediatric Tuberculosis in Bhopal, Madhya Pradesh, India: DOTS, Diagnosis, and Determinants" (2016). Independent
Study Project (ISP) Collection. 2316.
https://digitalcollections.sit.edu/isp_collection/2316

This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for
inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please
contact digitalcollections@sit.edu.

Paediatric Tuberculosis in Bhopal, Madhya
Pradesh, India: DOTS, Diagnosis, and
Determinants

Emma Klein
Dr. Azim Khan, Academic Director
Dr. Surya Bali, AIIMS Bhopal, ISP Advisor
SIT Study Abroad
India: Public Health, Policy Advocacy, and Community
Spring 2016

1

Acknowledgements
First, I’d like to thank Azim-ji and Abid-ji for their humor and support throughout
my project. Thanks to Bhavna-ji for teaching me Hindi and fashion sense, and Goutam-ji
and Archana-ji for being my surrogate parents. Huge thank you to the Jawa family for
hosting me during my time in Delhi and making my stay incredibly rich and warm. I’d also
like to thank Dr. Surya Bali for his guidance during this project and his willingness to take
me on as a student. I learned a huge amount from him and his colleagues. This project
would not have been possible Dr. Akash Ranjan Singh, who arranged most of my interviews
in Bhopal and offered invaluable guidance. I’d also like to thank Mr. Mukesh Nagar for
accompanying me, translating to the best of his ability, and being willing to make fun of me
when I totally failed. Mr. Sanjay Singh and Dr. Ravindra of the Community and Family
Medicine department offered guidance, companionship, and samosas. I’d also like to thank
Shiva for helping me with translation and making friends, and Sarasija and Ashish for
showing me all kinds of fun things to do in Bhopal. Thanks to the staff of the AIIMS Bhopal
guesthouse who were incredibly welcoming to me. Thanks also to the other SIT students
for their companionship and to my parents for offering love and support while I’m across
the world. Thanks most of all to all of the individuals who consented to be included in this
work, as without you, I would not have learned half so much or had this work to present.

2

Contents
Acknowledgements .............................................................................................................................................. 2
Glossary of Acronyms .......................................................................................................................................... 4
Abstract ..................................................................................................................................................................... 5
Introduction ............................................................................................................................................................ 6
Global and Indian Status of Paediatric TB .............................................................................................. 6
Social Determinants of Tuberculosis ........................................................................................................ 9
Field Study Objectives ................................................................................................................................. 10
Methodology ................................................................................................................................................... 11
Setting ........................................................................................................................................................... 11
Study Design ............................................................................................................................................... 12
Social Determinants of Paediatric TB......................................................................................................... 14
Background Data ........................................................................................................................................... 14
Age and Gender .............................................................................................................................................. 16
Malnutrition .................................................................................................................................................... 17
Household Contact ........................................................................................................................................ 20
Housing and Cooking ................................................................................................................................... 21
Socioeconomic Status .................................................................................................................................. 23
Health-Seeking Behavior ............................................................................................................................ 24
Healthcare Provider Challenges ................................................................................................................... 28
Diagnosis of Paediatric TB ......................................................................................................................... 28
Treatment of Paediatric TB ....................................................................................................................... 31
Prevention of Paediatric TB ...................................................................................................................... 32
Conclusions .......................................................................................................................................................... 35
Limitations ....................................................................................................................................................... 35
Recommendations for Further Study .................................................................................................... 35
Bibliography......................................................................................................................................................... 37
Primary Sources............................................................................................................................................. 37
Secondary Sources ........................................................................................................................................ 37

3

Glossary of Acronyms
AIIMS: All-India Institute of Medical Sciences
ANM: Auxillary Nurse Midwife
ATT: Anti-Tuberculosis Therapy
BCG: Bacille Camille-Guerin
CB-NAAT: Cartridge-Based Nucleic Acid Amplification Test
DMC: Designated Microscopy Center
DTC: District Tuberculosis Center
DOTS: Directly Observed Treatment Short-Course
DTO: District Tuberculosis Officer
HIV: Human Immunodeficiency Virus
JPH: Jay Prakash Hospital
MDR: Multiply Drug Resistant
MO: Medical Officer
MP: Madhya Pradesh
RNTCP: Revised National Tuberculosis Control Programme
SEAR: South-East Asia Region
TB: Tuberculosis
TBHV: Tuberculosis Health Visitor
TU: Tuberculosis Unit
WHO: World Health Organization
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Abstract
Tuberculosis (TB) is one of the world’s largest public health challenges, and it has a
disproportionate impact on India. In children, TB is a serious but understudied illness due
to the complexity of case-notification and relative lack of public health importance. This
study took place over the course of one month in Bhopal, Madhya Pradesh, India. In a
mixed method study consisting of 53 quantitative patient interviews and qualitative
interviews with healthcare providers, social determinants of TB in this setting were
investigated as well as challenges faced at all stages of healthcare delivery. Malnutrition
and housing were the most severe determinants of paediatric TB, though socioeconomic
status, age, and household contacts also played a role. Diagnosis continues to be a challenge
for healthcare providers. Overall, DOTS and the RNTCP is an effective public health
program to address paediatric TB, but to reduce incidence interventions on determinants
need to be prioritized.
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Introduction
Global and Indian Status of Paediatric TB
Tuberculosis (TB) is counted among HIV and malaria as one of the world’s most severe
infectious public health challenges. TB is caused by bacteria of genus Mycobacteria, usually
M. tuberculosis, and usually results in pulmonary disease, whose symptoms include chronic
cough, fever, and weight loss. The burden of TB lies disproportionately on low- and middleincome countries, with 22 high-burden countries responsible for over 70% of TB cases
worldwide1. The South-East Asia region (SEAR) accounts for an estimated 38% of the
global TB incidence; nearly two-thirds of these cases are from India2. India has the highest
burden of TB of any nation, due to its huge population and development status. However, it
performs slightly above average in terms of incidence, prevalence, and mortality rates in
the SEAR, which attests to the efficacy of the RNTCP despite the scale of the problem. An
estimated 10% of India’s TB caseload occurs in paediatric patients, due to its young
population, which is defined by the WHO as TB occurring in persons between 0-14 years of
age. Though paediatric TB is often neglected in national and international academic work,
policy, and awareness campaigns, several improvements are underway to improve casedetection and care for children with TB in India. In Madhya Pradesh, the site of this study,
1,00,034 cases of TB were registered for treatment in 2015, a case-notification rate of 131
per lakh population. Of these, 8,395 or 10% were paediatric patients3.
In India, several policies are in place by the RNTCP to address paediatric TB. The
most well-known and widely used of these strategies is the broad implementation of the
Swaminathan 2010.
WHO 2015.
3 India, Ministry of Health and Family Welfare, 2015.
1
2
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Bacille Camille-Guerin (BCG) vaccine. This is an immunization delivered to children
throughout India at birth, with estimated 91% coverage4. The BCG vaccine does not
prevent all forms of TB; instead, it protects children from severe, highly disseminated
forms of TB such as tubercular meningitis. It reduces mortality from paediatric TB but has
little impact on public health indicators such as incidence and prevalence. As children age,
the RNTCP recommends chemoprophylaxis to all children who are less than 6 years of age
or are immunocompromised and have a known contact with TB as a preventative measure.
For treatment, government clinics have pre-packaged boxes of drugs, incremented by
weight, which are provided for children with a TB diagnosis. This allows for 4 weight
categories, incremented by 6kg, for children of weights up to 30kg, at which point adult
treatment is recommended. Children are treated under Directly Observed Treatment Shortcourse (DOTS) protocol as are adults; however in paediatric patients the mothers can be
trained as DOTS providers to reduce strain on the family and ensure quality care for the
child. If this is undesirable, the community DOTS providers, often ASHAs or other
community health workers, are also trained to address paediatric TB cases. If convenient
and desired by the family, the DOTS providers are able to deliver the anti-tuberculosis
therapy (ATT) to the family’s home.
Despite these policies, the country still faces significant challenges in addressing
paediatric TB. Though estimates for the burden of paediatric case burden are around 10%
of all TB in India, only about 6% of reported TB cases are paediatric. This ratio hasn’t
changed for the past several years, indicating both systemic underreporting and a lack of
improvement. It’s likely that many of these cases are handled in the private sector, but
4

UNICEF, 2015.
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integration into government reporting services has been slow. Swaminathan and Sachdeva
identify seven key issues pertaining to childhood TB in India: integration of TB services
with the general health system, training of medical professionals, improving diagnosis,
screening of high-risk children, contact screening and chemoprophylaxis, treatment, and
drug-resistance5. The first two points, integration and training, will help to extend coverage
for TB to children who may not have access to TB centers or specialists. Paediatricians are
almost always the first medical professional to encounter sick children, so it is imperative
that they are trained in identification and diagnosis of paediatric TB. In addition ANMs and
ASHAs could play an important role in expanding identification and treatment of
impoverished children who have TB. Surprisingly, not all children in malnutrition wards
are screened for TB despite the increased risk, which could be a key area for improvement.
Diagnosis in India has been vastly improved since the introduction of cartridge-based
nucleic acid amplification test (CB-NAAT), a fast molecular biology diagnostic tool whose
use has expanded in India in the past few years. This not only speeds diagnosis, it is also
able to identify some of the resistance genes allowing for rapid detection of MDR strains.
This technology has been prioritized for paediatric cases. Access to this tool is limited to
tertiary-level care providers, so a continued expansion of the use of this technology as well
as training on laboratory sanitation techniques is imperative. Chemoprophylaxis is an area
in which India can improve, as 35-70% of eligible children did not receive this preventive
treatment6. Notably, none of the efforts mentioned in Swaminathan and Sachdeva’s article
mention social determinants, beyond family contacts. General improvement and expansion

5
6

Swaminathan 2015.
Swaminathan 2015.
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of India’s public health sector would likely address many of the missing paediatric TB
cases.

Social Determinants of Tuberculosis
Despite its historical connotation as a disease of poverty, current WHO guidelines
rely almost entirely on medical techniques to prevent TB. This is contradictory to historical
example; in Europe, sanitation and housing programs in cities led to the decline of TB
incidence long before the innovation of pharmaceutical interventions7. These strictly
medical interventions are mirrored in India’s RNTCP, whose TB control activities rely
mainly on DOTS treatment. Though implementation of DOTS has been effective in treating
ill patients and reducing prevalence of TB worldwide, incidence rates are stagnant,
illuminating the need to address the underlying social factors that contribute to disease. At
the global level, social determinants of TB can be separated into two broad classifications:
differential access to quality diagnosis, treatment and care; and differential risk of TB
exposure, infection and progression to disease8. The former category includes social factors
such as poverty, stigma, low awareness and education, financial and structural barriers
such as poor geographical coverage and low government health expenditure, and unequal
distribution of and access to social welfare programs. The second category includes
poverty, poor or nonexistent housing, urbanization, unhealthy lifestyle, and co-morbidities
including HIV, malnutrition, and non-communicable diseases. This split in social
determinants of disease conveniently mirrors agencies that should be responsible for
addressing each set of determinants – the first category handled by national tuberculosis

7
8

Lonnroth 2009.
Rasanathan 2011.
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programs (in India, RNTCP) and the second category by broader Ministry of Health and
social welfare ministries.
Though it has long been assumed that “…the epidemiology of childhood tuberculosis
follows that in adults,”9 there is emerging evidence that greater research needs to be done
on determinants in children for effective interventions at that level. Little of the literature
on social determinants mentions children or women, and this neglect is something that
must be addressed. Children are at higher risk for malnutrition than adults and it affects
their immune systems much more severely, so this determinant needs greater attention in
paediatric populations. Additionally, household and community crowding and proximity to
infectious adults have greater impact on children due to their inability to travel far from
their homes. Because of this, indoor air pollution may have a larger impact on children as
well. However, none of this is as well-established as in adult populations, and “more studies
are needed in low-income countries to examine specific risk factors for TB in children.”10

Field Study Objectives
This study aims to discover the status of paediatric tuberculosis in Bhopal, Madhya
Pradesh, India. It aims to illuminate the factors that increase children’s vulnerability to TB
infection and reduce their access to treatment. Social determinants of TB are well-studied,
but much of the existing literature excludes paediatric patients. Children are a particularly
vulnerable segment of society so it is especially important to put a strong focus on their
health. In addition, the TB status of children is a good indicator of community health, so
fully understanding childhood TB will lead to generally improved TB prevention in a
system with effective contact-tracing. This study will contribute to the body of knowledge
9

Kabra 2004.
Nelson 2004.
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regarding root causes of TB in children such that community-level interventions can be
more effective. With this purpose in mind, this study will also investigate current
interventions with respect to paediatric TB in Bhopal and in MP. In short, this study aims to
answer the following questions: Which factors contribute most significantly to paediatric
TB in Bhopal, and how could they be best addressed? What are the greatest challenges for
effective diagnosis, treatment, and prevention of paediatric TB? Where are the gaps in
coverage of intervention on behalf of paediatric TB patients and how could those be
addressed?

Methodology
Setting
Madhya Pradesh is the second largest state and is situated in central India. Bhopal
district is centrally located within this state, with population of 2.53 million and is
predominantly urban, holding the city of Bhopal, capital of Madhya Pradesh. RNTCP
infrastructure in Bhopal district includes one District TB Centre (DTC), five sub-district
level programme management units (Tuberculosis Units - TU) and 27 designated
microscopic centres (DMCs) for sputum acid-fast bacilli examination. Among 27 DMCs, 6
are located in medical colleges, 1 in district level hospital and 20 in primary/secondary
level health centres. Each DMC is staffed by a tuberculosis health visitor (TBHV) whose job
involves registering patients and overseeing the DOTS program in his/her DMC. The
treatment of individual patients is supervised by DOT providers, usually community health
workers trained in the DOTS regimen, to ensure appropriate and complete treatment. They
act as link between the formal health system and the community for treatment of TB; they
are expected to provide supervision for the treatment duration and counselling services, as
well as facilitate scheduled sputum examination and screening of household contacts of an
11

index case if needed. In addition, in the treatment of paediatric TB the mother of the
patients is permitted to register as a DOT provider for her child, in order to ease the burden
on the family and ensure high-quality care for the child. Patients are referred to the DOTS
program for treatment by physicians after diagnosis of TB. In paediatric patients, the
referring physician is a paediatrician, usually from the government healthcare system
though private sector participation in RNTCP is increasing in Bhopal district.
This study was conducted over a span of four weeks in two Bhopal district TUs: Jay
Prakash Hospital (JPH) and District Tuberculosis Center (DTC). These two TUs are both
urban and include a combined 13 DMCs, at which the study was conducted. The study
population was all paediatric TB patients registered in these two TUs in the first quarter of
2016. This totaled 63 registered patients. With permission from DTO Dr. Manoj Verma and
cooperation with TBHVs at each DMC, information was gathered about the study
population. In addition, qualitative interviews were conducted with select patients, DOT
providers, TBHVs, doctors, and other relevant health-sector employees in the areas
covered by the selected TUs.
Study Design
The quantitative portion of this study relies on questionnaire responses from the
families of paediatric patients from the study population. This questionnaire is attached as
Appendix 1. This is meant to probe for demographic information about the patients and
their families correlated to known social determinants of TB in adults and children. Basic
information regarding the child’s illness as well as experiences with and accessibility to
government services will also be collected. Lacking a control population, this study will
instead rely on knowledge from previous literature and public census data for
12

comparisons. These interviews largely occurred at the DMCs at which patients were
registered. Patients were requested to come to the DMC by the TBHV, where informed
consent was obtained and the interview was conducted in Hindi. Some interviews were
conducted at the patients’ homes, escorted by a DOT provider and with permission from
the family. This was not widely attempted out of respect for the privacy of patients and
their families. A select number of interviews were conducted over the phone for patients
who were otherwise unreachable in order to increase the yield. A total of 53 patients were
interviewed for the quantitative portion of this study.
The interview respondents are the escorts of the patients to the DMC on the date on
which that interview was conducted. Usually, this was the parents of a patient. Sometimes,
a patient was accompanied by another family member, such as an older sibling, aunt, uncle,
or grandparent. A handful of patients were escorted by community health workers or other
third parties. Some responses to the questionnaire were obtained directly from the RNTCP
registration card of patients. Most notably, patient’s weight was sometimes from the most
recent addition to their registration card, sometimes taken at the time of the interview on
an available scale, and sometimes estimated by the parents. This was variable depending
on DMC, since easy access to the card was only available in some areas. All responses are
subject to the knowledge and biases of the respondents; in particular reports of TB
contacts in the household and community and income are highly subject to bias.
In addition, this quantitative data is supplemented by qualitative data taken from indepth interviews and personal observations. Some families were identified for further
questioning during the questionnaire process based on their apparent knowledge, interest,
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and willingness to share on the topic of their child’s illness. These families were asked to
participate in a longer, in-depth interview with open-ended questions probing their
experiences with their child’s illness, including challenges in accessing diagnosis and
treatment services, financial and social barriers to care, and narratives of how the illness
has affected their family. The interview guide for families of patients can be found in
Appendix 2. This is intended to show the personal and human challenges faced by
paediatric TB patients and their families, as well as illuminate knowledge about the illness.
In-depth interviews were conducted with 1 pulmonologist, 3 paediatricians, 1 medical
officer (MO), 3 TBHVs, 1 DOT provider, and 1 private pharmacist. These interviews focused
on the challenges faced in adequate case-finding, diagnosis, and treatment, including
adherence, from the medical perspective, as well as public health challenges faced by
health workers. This interview guide for healthcare providers can be found in Appendix 3.
Medical professionals should be able to illuminate any particular challenges in dealing with
paediatric TB that the researcher may have overlooked, as well as providing information
about interventions currently prescribed by the Revised National Tuberculosis Control
Program (RNTCP). The integration of the knowledge of medical professionals with the
experiences of the patients is intended to give a complete snapshot of the challenges in
addressing paediatric TB in Bhopal.

Social Determinants of Paediatric TB
Background Data
All participants in this study were of 18 years of age and consented to be
interviewed for the purpose of this work. A total of 53 patients’ families were interviewed

14

between 18 April and 7 May 2016. The patients were spread across 13 DMCs in Bhopal city.
All were undergoing treatment under the RNTCP and were within the purview of the
government healthcare system. Most patients were undergoing category I treatment under
DOTS, which is for newly registered patients. A few patients were taking category II
treatment, which is for relapse, treatment failure, or other cases where the first course did
not work.
Since this study is focused on paediatric TB, it was imperative to focus on all types of
TB disease. TB is classified into two general types: pulmonary and extrapulmonary,
depending on the location of infection. Children are much more susceptible to
extrapulmonary disease than adults. In this study, 60% (32/53) patients had
extrapulmonary TB and 40% (21/53) had pulmonary TB. Data on smear-positive or smearnegative status was not collected. Of the extrapulmonary cases, lymph node TB was the
most common location, though Koch’s abdomen and nervous system infections were also
relatively frequent.
All patients were currently undergoing DOTS treatment, but were at different stages
in the process. Category I DOTS protocol is divided into two phases: the 2-month intensive
phase is followed by the 4-month continuation phase. The drug regimen is different
between phases: the intensive phase involves thrice weekly doses of rifampicin, isoniazid,
pyrazinamide, and ethambutol, while the continuation phase is a daily dose of medication,
either rifampicin and isoniazid (3x weekly) or pyridoxine (4x weekly). Treatment may last
longer than 6 months when desired results are not achieved within the time frame. A
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summary of the time on which patients had been receiving DOTS treatment can be found in
Figure 1.

Figure 1. Histogram of time on DOTS
treatment
30

FREQUENCY

25
20
15
10
5
0
0-1 month

2-3 month

4-5 month

6+ month

TIME

Most patients in this study had completed the intensive phase (here denoted by the
0-1 month bin on the histogram) and proceeded into the continuation phase. This data is
subject to error due to estimates on the part of the parents when exact dates were not
obtained from medical documents.

Age and Gender
To analyze if there is a gender bias in the treatment of paediatric TB in Bhopal, the
gender breakdown of the study sample was analyzed. Of the 53 patients in the study, 26
were female and 27 were male. The sex ratio of Bhopal district is 920 women to 1000
men11. There is no significant difference between the population of Bhopal and the sample
in the study, thus there is no gender bias in the RNTCP in Bhopal district.
The risk of developing TB disease after infection is age-dependent. From
Swaminathan and Rekha 2010: “Young age and HIV infection are the most important risk
11

Bhopal District: Census 2011.
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factors for severe or disseminated disease; the risk of disease progression decreases during
childhood, is least at 5–10 years of age, and increases again during adolescence12.” The age
and gender breakdown of the study sample is visible in Figure 2.

Figure 2: Age of paediatric TB
patients
Girls
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To some extent, the expected trend as outlined by Swaminathan and Rekha is seen
in the data. There is a higher number of very young cases in comparison to those in the 4-7
age range. However, cases increase before adolescence and drop off once patients become
preteens. This premature rise in case frequency with respect to age could be due to an
increased ability of slightly older children to communicate their symptoms to their parents
in comparison to their younger peers. The drop-off in adolescent case frequency could be
due to a greater awareness of stigma as children age, especially in girls, who are
underrepresented in the oldest age bracket.

Malnutrition
In an attempt to gauge the prevalence of malnutrition in the paediatric TB
population in Bhopal, age and weight at the time of diagnosis were collected for all patients
12

Swaminathan 2010.
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surveyed. Using WHO weight-for-age tables, Z-scores were assigned to all patients 10 years
of age or younger, a total of 37 patients13. These Z-scores were integers and did not exceed
an absolute value of 3. Since date of birth was not taken, and the age in months of the child
was unavailable, the integer age of each child was used with the WHO field tables. The
results are displayed in Figure 3.

Figure 3: Histogram of Weight-forage Z-scores in sample population
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The mean z-score among surveyed paediatric TB patients was -1.70 and the
standard deviation was 1.11. This is significantly different from an expected distribution
where the mean is 0 (p<0.01, 1-tailed z-test). Though weight-for-age is by no means a
comprehensive measure of nutritional status, this indicates a strong bias toward children
who are undernourished in the paediatric TB population of Bhopal. According to the WHO,
this is worrisome not just for the sample that is undernourished but indicates populationscale interventions are necessary14. 2.3% of the population is expected to have a Z-score of
13

WHO Child Growth Standards.
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less than -2, meaning that it is possible some of this sample population is not truly
undernourished. However, with 44% of the population having Z-scores of this magnitude,
the WHO would classify the severity of malnutrition as “very high” by the weight-for-age
indicator. Taken all together, this indicates that malnutrition is a highly significant comorbidity for TB in Bhopal district.
Weight at the time of interview was also collected. One symptom of tuberculosis is
weight loss, so in malnourished children, TB can exacerbate the problem. Treatment under
DOTS is expected to increase the weight of the child in question. The weight of each child in
the sample at the time of diagnosis and at the time of interview was compared in a paired ttest. The weight at the time of interview was found to be significantly higher (p<0.01) than
at the time of diagnosis by an average of 1.2 kg. Given that the time since diagnosis was
different for each child, with an average of around 2.5 months, this indicates significant
improvement in nutritional status with tuberculosis treatment.
Bhopal district is working to improve TB case detection in malnourished children.
Paediatricians screen patients who come to nutrition rehabilitation centers (NRCs) for TB,
especially children resistant to gaining weight when in the hospital and on a proper diet.
Several of the patients included in this study were referred to the RNTCP from the NRC
after treatment for malnutrition, especially patients 2 years of age or younger. This is
especially effective in identifying infants and toddlers with pulmonary TB, as its symptoms
are usually less severe and less likely to warrant a doctor’s visit. The efficacy of these crossreferrals could be improved if a greater age range was eligible for treatment at the NRC and
if malnutrition services and screenings were more widely available and utilized.
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Household Contact
One of the most common and well-known risk factors for paediatric TB is the
presence of a sputum-positive adult patient within the same household. This is why
chemoprophylaxis is available through the RNTCP in Bhopal district for all children 6 years
of age or younger with sputum-positive household contacts15. However, this is not always
provided or taken regularly by the children. Additionally, children older than 6 are not
offered chemoprophylaxis at all. To gauge the prevalence of known household and
community contacts, the patients were asked 3 questions: Does anyone in your family have
TB? Does anyone in your family have chronic cough? Do any neighbors or community
members have TB or chronic cough? The results are aggregated in Table 1.
Table 1: Reported contacts of paediatric TB patients
Classification Known
Possible
Known
Household +
Household
Household
Community
Community
Contact
Contact
Contact
Contact
Count 15
2
5
2
Percentage 28%
4%
9%
4%
This totals to 45% of the study sample having some kind of known contact.

No
Known
Contact
29
55%

Paediatricians at AIIMS Bhopal reported that out of every 5 TB patients, 2-3 would have a
traceable contact16. This aligns with the data found in this study. In addition,
underreporting is very likely due to the social stigma associated with TB. People are not
likely to know the TB status of their neighbors; healthcare providers generally agreed that
when there is no traceable contact a new case of paediatric TB is due to a community
member whose illness is not public knowledge. Additionally, many are reluctant to admit,

15
16

MO, JK Hospital, 2016.
Bhatt 2016.
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even to the researcher, that there is TB in their family. Accounting for these two factors
would likely boost the total number of paediatric TB cases in this study with contacts.

Housing and Cooking
Two main types of housing are prevalent in India, called kutcha and pucca. A pucca
house could be translated to a permanent house in English; it is made of high-quality
materials including floor, walls, and roof. Kutcha homes are made of thatch, mud, and other
such materials. Homes made with a mixture of materials are called semi-pucca. Housing is
an important determinant of tuberculosis because of its respiratory mode of transmission.
A poorly ventilated home increases the chance of TB transmission. In addition, knowledge
about the type of home in which someone resides gives evidence by proxy of the type of
community in which they live. Communities with mainly kutcha homes tend to be more
crowded, slum-type areas where rates of TB are high. The self-reported housing type of
study participants is found in Figure 4.

Figure 4. Housing of paediatric TB
patients
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Approximately equal numbers of paediatric TB patients surveyed in this study live
in kutcha and pucca homes. However, in urban communities in Madhya Pradesh, 93.2% of
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homes are pucca and only 1.2% are kutcha17. By this standard, a huge proportion of
paediatric TB patients live in low-quality housing, with a statistically significant difference
(p<0.01, chi-squared test). Poor housing is a highly significant determinant in the
landscape of paediatric TB in Bhopal. This provides strong evidence that further action on
determinants is necessary to adequately prevent TB. No part of the RNTCP acts to improve
the housing in which TB patients live, yet it is clearly a highly influential factor.
Cooking fuel is also a determinant of tuberculosis. Indoor air pollution creates stress
on the lungs and thus increases likelihood of TB disease. Three types of cooking fuel are
common in India, listed here in order of cleanliness for the lungs: LPG (gas), kerosene, and
cow dung. To gauge the effect of indoor air pollution due to cooking as a determinant of
paediatric TB, the fuel preferred by each family was collected. The majority of families use
LPG, which indicates that cooking fuel is not a very important determinant of paediatric TB
in Bhopal. Full results can be found in Figure 5.

Figure 5. Cooking fuel used in homes of
paediatric TB patients
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India, Ministry of Statistics and Programme Implementation, 2015.
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Socioeconomic Status
To analyze the socioeconomic status of patients of paediatric TB, information on
household occupation, education, and income was collected. This was all self-reported by
the escort of the child to the DOTS center and is subject to bias. In cases where the
educational attainment differed between the mother and father, an approximate average
was used as the household score, with more emphasis on the education of the primary
wage earner. When both parents were employed in different-status jobs, an in-between
score was given, with emphasis on the higher-status job. This information was consolidated
into a Kuppuswamy score for each family. In this system, a numerical value is assigned to a
household based upon each of the categories previously mentioned18. When added, the
score acts as an indicator of socioeconomic status. Income scores were calculated for this
study using real-time data and an online calculator19. The results can be seen in Figure 6.

Figure 6. Kuppuswamy classes of
paediatric TB patients' families
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Kuppuswamy is only an approximate indicator of socioeconomic status, however
this data provides a baseline snapshot of class disparities in paediatric TB in Bhopal. The
mean Kuppuswamy score was 8.9 with standard deviation 3.4; the median was 8. TB is
well-known as a disease of the poor and that is confirmed by these results, where the vast
majority of patients fall into the “upper lower” class. Most surprising is the low level of
lower-class patients. This could be due to a lack of awareness amongst the poorest about
paediatric TB, or a lack of access to government services. Possibly the upper lower class
patients have improved literacy and are more able to miss work than the lower class
patients. In addition, some paediatric TB cases are handled by the private healthcare
system, but the class breakdown of these patients is unknown.

Health-Seeking Behavior
In order to be included in this study, each patient had to access the government
healthcare system in Bhopal. This process is not always straightforward and involves many
steps, including recognizing illness, going to a doctor, waiting for a diagnosis, and referral
to the nearest DOT center. To complement the data on determinants, data was gathered on
some basic health-seeking behaviors of paediatric TB patients and their families in order to
assess the challenges they may have faced. First, patients’ families were asked how long the
patient was sick before seeking treatment. Results are presented in Figure 7.
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Figure 7. Time between onset of illness
and treatment-seeking in paediatric TB
patients
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This data is self-reported and may be skewed toward shorter periods of time, which
is a bias towards good caregiving. Some of the patients who fall into the “less than 1 month”
category were victims of acute TB disease such as meningitis, and due to the severity of the
symptoms, visited the hospital quickly. Other patients in this category include patients
referred from the NRC who were not showing symptoms noticeable to the parents but
were detected by medical professionals. With these caveats, most patients visited a doctor
within one month of noticing illness, which demonstrates a good level of education about
symptoms. In addition, this question was difficult to translate and not worded very clearly,
so this time may include time spent with private doctors for treatment for some patients,
especially for those greater than 6 months. Many of those patients reported a time in years.
To attempt to understand the behavior of patients and private healthcare providers
in the context of paediatric TB, patients’ families were asked if they had been to private
doctors before they were enrolled in DOTS. Private and public collaboration on TB has not
always been strong, but for effective treatment, prevention, and reporting, the private
sector needs to work closely with the RNTCP. Results are in Figure 8.
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Figure 8. Private doctors visited before seeking
government healthcare for paediatric TB
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In this sample, approximately 2/3 of patients did not go to a private doctor or only
saw one before they were referred or changed their mind. The survey format of this study
was not able to explore the patient’s reasons for choosing private doctors or for changing
their doctors. However, doctors at AIIMS noted that private doctors are becoming more
cooperative with the government on paediatric TB in recent years and are more likely to
refer patients to RNTCP DOTS centers20. The high number of patients who saw only a single
private doctor compared to those who saw more supports the conclusion that the private
sector is working relatively well with the government, though no conclusion can be drawn
about the change over time.
Another possible barrier to treatment is the distance a patient is required to travel
to get medicine. In treatment of paediatric TB with DOTS through RNTCP, the family of the
patient has 3 options: they can travel to the DOTS center to receive treatment, they can
have treatment delivered to their home by the DOTS provider, or the mother can be trained
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as a DOTS provider for her child. The distance is an important factor because the further
away and more inconvenient the DOTS center is, the less likely a patient is to go receive
treatment. Travelling costs money and the more time the appointment take, the more
hours of work are lost. A summary of the distances can be found in Figure 9.
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That said, most patients lived relatively close to their DOTS centers. The mean
distance was 1.7 km with standard deviation 1.5 km. This distance is easily travelled by
bike or auto and can be walked if necessary. Some patients did not know how far this
distance was. Though it wasn’t specifically asked, in this study 20% of patients reported
that the treatment was delivered to their home by the DOTS provider. The mean distance to
this subset of patient’s homes was 1.8 km, and this difference is not statistically significant
(p=0.43, 2-sample t-test). This low rate is partially due to the lack of question on the
questionnaire but also due to stigma. Families who do not want their neighbors to know
their child has TB do not want a DOTS provider visiting their home three times a week.
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Community awareness and decreasing stigma would ease the burden on families with
children with TB.

Healthcare Provider Challenges
Diagnosis of Paediatric TB
Diagnosis of paediatric TB provides the biggest barrier to effective reporting of
paediatric cases. Even with modern technology, it is extremely difficult to produce an
accurate diagnosis of paediatric patients. In developed countries, use of the tuberculin skin
test (TST or Montauk’s test) for TB diagnosis is standard practice, but in India and other
developing countries where the BCG vaccine is used, this test is not as useful21. It can only
identify that a patient has been exposed to TB but not whether the current disease is in fact
TB. Instead, in adults, the standard diagnostic procedure of TB in endemic countries relies
on sputum analysis. This leads to the common classifications of smear-positive or smearnegative, which is dependent on the presence of TB bacilli in the sputum. However,
children are usually not able to produce sputum for this test, and the diagnostic categories
used in adult TB cases are not useful in children. This leads to a complicated diagnostic
formula for paediatric TB involving contact tracing, symptom analysis, and response to
standard antibiotic therapy. In addition, paediatric patients are more likely to have
extrapulmonary TB than adults, which further complicates diagnosis. In practice, a wide
variety of diagnostic tests are used, especially in extrapulmonary illness. New methods
using molecular biology and other techniques are in development, but even where these
are promising, they are tested in adults and not paediatric patients. One of the foremost
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challenges in treating paediatric TB is effective and rapid diagnosis, especially when drug
resistance is suspected.
Paediatricians at AIIMS shed some light on their diagnostic process for paediatric
TB. All 3 interviewed called the process difficult and each highlighted different challenges.
These interviews confirmed the literature about the difficulty of sputum production. The
alternative to this procedure is gastric lavage, but Dr. Shiv Dubey, paediatrics resident at
AIIMS Bhopal, emphasized that it is less than ideal as a substitute due to its low sensitivity
of 30%22. Notably, all three doctors answered exclusively in response to the diagnosis of
pulmonary TB, and did not provide information on extrapulmonary until prompted by the
researcher. Diagnosis of extrapulmonary TB is also challenging because of the wide range
of presentations it can have. Key symptoms include vague and general problems like
weight loss or inability to gain weight and fever, according to Dr. Nena Shrivastava,
paediatrics resident at AIIMS Bhopal23. A wide variety of diagnostic procedures are used
including x-ray, ultrasound, and biopsy, and there is increased suspicion when a known
contact exists. This was demonstrated in the quantitative interviews of patients, who
reported diagnostic procedures ranging from Montauk’s test and the very generic “blood”
test to ultrasounds and cerebrospinal fluid analyses (in the case of meningitis). Because
AIIMS is a prestigious medical college, there is also access to a new molecular diagnostic
technique called CB-NAAT. This is used in adult patients primarily for drug susceptibility
testing but has moderate efficacy as a diagnostic technology for paediatric patients. Dr.
Girish Bhatt, associate professor of paediatrics at AIIMS Bhopal, says that they use this
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technology in cases of high suspicion24. However, caution needs to be exercised in relying
upon this technology for diagnosis, despite its immense power. Because TB is so common
in India, and because sanitary laboratory practices are not often followed rigorously,
contamination of samples is easy and can contribute to false positive diagnoses, according
to associate professor of pulmonology at AIIMS Bhopal Dr. Alkeesh Khurana25. Ultimately,
many patients are diagnosed after their illness does not respond to ordinary antibiotic
treatment.
Diagnosis provides an interesting stage for interaction with the private sector.
Because many private doctors are limited by resources, Dr. Girish notes that they
sometimes refer patients to AIIMS when they have difficulty in diagnosis. This is especially
pronounced with the availability of the CB-NAAT test26. According to Dr. Alkeesh, the
private sector’s involvement in TB control activities has improved in recent years. He says:
“…when I joined [pulmonology, 12 years ago] the private sector was
reluctant to collaborate with the public sector due to some issues like
financial issues or lack of trust with the policies, but I think the RNTCP in
India has now broadly incorporated private sector also… The government
has deliberately involved private sector more in the last 10 years to make
them an integral part of this program. I have seen in the private sector
doctors who, instead of prescribing ATT daily non-DOTS, they are referring
[TB patients] to the DOTS centres.”
This increased involvement of the private sector in TB control activities is extremely
helpful for patients. Though there is still a long ways to go, this seems to be a huge step
forward for public-private partnerships in TB care in India.
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Treatment of Paediatric TB
Treatment of paediatric TB can be problematic. When a child is suspected to have
TB, they are prescribed treatment through DOTS, just like an adult patient. In Bhopal, the
option of having the mother be a DOTS provider for the child allows flexibility for the
family and more individualized care for the child. When the mother is willing and able to be
an effective DOTS provider, this option removes the need for the family to travel thrice
weekly to the DOTS center, as the mother will keep the box of drugs. Several of the doctors
interviewed mentioned the financial burden of the lost wages and transit to the hospital,
but this action can greatly reduce these costs27. Generally, interviewed subjects spoke well
of the RNTCP, nobody doubted its efficacy or coverage in either adults or children.
The only complaint about treatment of paediatric TB from medical professionals
had to do with the drugs. Drug dosages for paediatric patients are extrapolated from adult
data and are often not accurate for a child’s metabolism28. This leads to higher rates of
treatment failure in children than adults in general. In addition, when paediatric patients
do get MDR-TB, the second-line drugs are not well formulated for children, which makes
treating this difficult disease even trickier. Another huge concern is the administration of
drugs to paediatric patients. The current DOTS formulations provided by the RNTCP are
simple pills that need to be swallowed. However, it is challenging to get children to take
these drugs, and dispersible tablets or liquid delivery would be much preferred29. Private
pharmacists offer dispersible ATT to paediatric patients, but this is not the RNTCP
recommended formulation nor is it subject to DOTS. Additionally, there are challenges
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when patients have adverse reactions to drugs. Though rare, especially in children, patients
sometimes require individualized ATT due to allergies or other problems30. This is very
challenging to administer through DOTS because the preset drug regimens do not allow
flexibility.

Prevention of Paediatric TB
Prevention of TB in paediatric patients relies on two main medical interventions:
the Bacille Camille-Guerin (BCG) vaccine and chemoprophylaxis. The BCG vaccine is given
to every infant at birth in India, and coverage is upwards of 90%31. However, BCG
vaccination does not prevent all TB infection but only reduces incidence of severe
disseminated forms of the disease. It significantly reduces mortality from paediatric TB
infection but does not prevent all childhood illness. As stated in Nelson 2004, “…a strategy
of BCG vaccination at birth alone will not adequately reduce the burden of childhood TB.”32
This was confirmed by findings in Bhopal. At least one child in the sample had received the
BCG vaccine and still suffered from TB meningitis because the protection only lasted one
year. The sheer number of paediatric patients in Bhopal indicates that BCG is not effective
in true prevention of paediatric TB.
Additionally, chemoprophylaxis, or preventative pharmaceuticals, is recommended
to all children less than 6 years of age with a household member with active TB infection. It
is critically important to verify that the child does not have TB infection at the time of
prescription, since only a single drug is given33. Unscrupulousness can result in drug
resistance. Importantly, most paediatric TB cases can be traced to household contacts, so
Shrivastava, 2016.
Swaminathan 2015.
32 Nelson 2004.
33 Singh, Personal Interview, 2016.
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effective implementation of this preventative measure could vastly reduce the burden of
paediatric TB. Despite this recommendation, and despite access to chemoprophylaxis
through the RNTCP DOTS centers, not all patients recommended to take chemoprophylaxis
actually did, especially for the full 6 months. In addition, though few cases less than 6 in the
quantitative survey had household contacts, several of the older children did. The RNTCP
might benefit from broadening the age range to which chemoprophylaxis is accessible.
A significant barrier to proper prevention of paediatric TB in Bhopal is the
continued stigma against TB. One of the most effective methods to prevent TB is contact
tracing – tracking down those who new TB patients are in close contact with and screening
for TB. Currently, the RNTCP is not involved in active case screening. However, the stigma
against TB makes it incredibly challenging for medical professionals to track down
individuals with active TB disease, even if they were able to. For this study, which focused
on known TB patients, the researcher had to ask about chronic cough instead of using the
word “tuberculosis” for some interviewees to admit to having TB in their household.
Without patients’ willingness to cooperate, any public health system intervention is
doomed to fail. Additionally, improved education and awareness of TB is required. In
Bhopal, the DOTS centers organize World TB Day events and hold monthly meetings where
new patients can meet with old patients to learn about TB. The community is definitely
working towards improved TB awareness, though there is a long way to go, especially with
paediatric TB.
Every healthcare professional spoken to for this study spoke highly of DOTS and the
RNTCP. Most patients were satisfied with their treatment under the RNTCP as well. Patient
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suggestions include more staff, staff who work their full hours (9am-5pm instead of the
closing at 1 or 2pm that is standard), and increased advertising on TV and radio. Evidence
supports this assessment of both patients and medical professionals: TB prevalence in
India has declined quite rapidly in the past 10-15 years, since the inception of the RNTCP34.
The RNTCP is working phenomenally well in a resource-limited setting; but to truly reduce
paediatric TB incidence, action must be taken on the social determinants.
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Conclusions
This study has illuminated the relative importance of various social determinants of
paediatric TB in Bhopal. Malnutrition plays a huge role in tuberculosis infection in children,
with the study sample weighing significantly less than WHO standards. Because TB and
malnutrition each exacerbate the other, this is a critical finding of the study and target for
action. Additionally, poor housing plays a significant role in paediatric TB infection.
Significantly higher numbers of paediatric TB patients reside in impermanent housing than
the general population of Bhopal. Socioeconomic status, the presence of household
contacts, and age also play a role. Healthcare providers face significant obstacles in
diagnosis, but the doctors included in this study were very aware of the problems and their
possible solutions. Overall, despite a highly regarded government DOTS program, social
determinants analysis reveals severe disparities in healthcare among some segments of the
young population.

Limitations
This study was limited to certain areas of Bhopal district and cannot be generalized.
The quantitative portion of the study was based upon voluntary participation and does not
represent a random sample of paediatric TB cases in Bhopal. A sample size of 53 is not
large enough to draw any firm conclusions. Additionally, the doctors interviewed all
worked at AIIMS, a prestigious medical school. Their knowledge is likely greater than the
average doctor treating TB, and they do not represent a common standard of knowledge.
Hindi translations may not be completely accurate.

Recommendations for Further Study
Because paediatric TB is so understudied, there is lots of space for further study in
the topic. This study chose not to focus on the prominent issues of TB/HIV coinfection and
35

MDR-TB due to time and sensitivity concerns, but both would be valid and interesting
subjects to explore in a paediatric context. Paediatric TB and malnutrition is a fascinating
set of co-morbidities whose high significance merits more study. Operational research
could be conducted on the use of either chemoprophylaxis or BCG vaccine, i.e. investigating
whether these interventions are used where they are supposed to be. Lastly, research not
on paediatric TB, but on TB’s effects on the family could be of value. For example, does a
parent’s TB increase the likelihood that his/her child drops out of school? Do children
suffer worse non-TB health outcomes?
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Appendices
Appendix 1
Questionnaire for Paediatric TB Patients
1.
2.
3.
4.

TB Reg no/ lab no:
Age:
Sex:
Is your child in school?
a. If yes, which standard?
b. If no, because of disease?
5. Weight at diagnosis:
6. Present weight:
7. Pulmonary or extrapulmonary?
8. How was the TB diagnosed?
a. Clinical
b. Sputum
c. Gastric Lavage
d. other
9. How long was your child sick before seeking treatment?
a. <1 month
b. 1-3 months
c. 3-6 months
d. >6 months
10. Did you see a private doctor before going to the government system?
a. If yes, how many?
11. How many kilometers do you have to travel to get your child’s treatment?
a. <3
b. 3-6
c. >6
12. For how long has your child been taking the medicine?
a. 0-2 months
b. 2-4 months
c. 4-6 months
d. >6 months
13. Does anyone else in your family or relatives have a TB diagnosis?
a. If yes, was the child offered chemoprophylaxis?
14. Does anyone in your family/relatives have chronic cough?
15. Do others in your community have TB or chronic cough, as far as you know?
16. What housing do you live in?
a. Kuccha
b. Pukka
c. Semi-kuccha
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17. What fuel do you use to cook food?
a. LPG
b. Kerosene
c. Cow dung
d. others
18. What is your monthly income?
a. Above 10000
b. 5000-10000
c. 2500-5000
d. 1000-2500
e. Less than 1000
19. What is your education level?
a. Professional or honours
b. Graduate or Post-graduate
c. Intermediate or Post-High shool diploma
d. High school cerificate
e. Middle school certificate
f. Primary school certificate
g. Illiterate
20. What is your occupation?
a. Profession
b. Semi-profession
c. Clerical, Shop owner, farmer
d. Skilled worker
e. Semi-skilled worker
f. Unskilled worker
g. Unemployed
21. Do you have a BPL card?

Appendix 2
Interview Guide on Pediatric TB: Patient’s Families
1. Has your child ever had to miss treatment? Why?
2. How do the drugs affect your child?
3. How has your life changed since your child’s diagnosis? What challenges has your
child’s illness caused in your life?
4. What did you know about TB before your child’s diagnosis? What have you learned?
What do you wish you knew?
5. Does your child face stigma in your community? What does that look like?
6. What could the government do better to reach other children with TB?
7. Tell me about your community. Do you like living here? What are the upsides and
downsides? How is the health of people who live here?
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Appendix 3
Interview Guide on Pediatric TB: Health care providers
1. What is your name? What is your job title?
2. How frequently do you treat children with TB?
3. How do you diagnose children with TB? What is the most difficult part about
diagnosing children with TB?
4. How are pediatric TB patients referred to you/to whom do you refer suspected TB
cases? Do you coordinate with health care providers from other departments
(pediatrics, malnutrition, etc.)?
5. In your experience, do most pediatric TB cases come from household contacts?
a. If no, from where?
6. How easily available is chemoprophylaxis? Do you recommend it to all adults with
children seeking TB treatment?
7. What burdens does having a child with TB place on his/her parents? Are the parents
still able to work?
8. What do you tell the parents of the child who is diagnosed with TB?
9. How is adherence in pediatric patients? How is MDR/XDR handled differently in
pediatric patients?
10. What is awareness of pediatric TB like in the community? What is being done to
address it? Do children face stigma?
11. What role is played by the private sector in treatment of pediatric TB? Do you think
they are effective? How can they be more effective?
12. What do you think are the strengths and weaknesses of the RNTCP in addressing
pediatric TB?
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